Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]

ER positive breast cancer: Screening for clinical variables to predict late...

Dr Ivana Sestak - Queen Mary University of London, London, UK

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence ( Dr Ivana Sestak - Queen Mary University of London, London, UK )

Predicting late breast cancer recurrence with screening assays

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK

Predicting late breast cancer recurrence with screening assays ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK )

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression...

Prof Gini Fleming - University of Chicago, Chicago, USA

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone ( Prof Gini Fleming - University of Chicago, Chicago, USA )

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA

CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )

How can scalp-cooling reduce chemotherapy induced hair loss?

Richard Paxman - Paxman Coolers Ltd

How can scalp-cooling reduce chemotherapy induced hair loss? ( Richard Paxman - Paxman Coolers Ltd )

Acupuncture significantly reduces joint pain for breast cancer patients

Prof Dawn Hershman - Columbia University Medical Center, New York, NY

Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )

Phase III trial data supports current standard 12-month adjuvant trastuzumab...

Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland

Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer ( Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland )

Temporary ovarian suppression with hormone analogue may preserve fertility...

Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium

Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy ( Dr Matteo Lambertini - Institut Jules Bordet, Brussels, Belgium )

Two years of extended anastrozole therapy as effective as five

Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

Two years of extended anastrozole therapy as effective as five ( Prof Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )

Tandem duplicator phenotypes define 50% of triple negative breast cancers

Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA

Tandem duplicator phenotypes define 50% of triple negative breast cancers ( Dr Ed Liu - The Jackson Laboratory, Bar Harbor, USA )

Updated genomic screening tool for life-time breast cancer risk

Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...

Updated genomic screening tool for life-time breast cancer risk ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )

More from ecancer